YOLFTbeta
00

Baolingbao Biology Co Ltd

002286 · SHE · Healthcare / Biotechnology

8.95CNY+0.15 (+1.70%)

Price History

Full chart

Market Stats

Previous Close8.80
Open9.50
Day Range8.78 – 9.68
52-Week Range7.15 – 11.51
Volume37.09M
Market Cap3.16B
P/E (TTM)21.89
Forward P/E18.15
EPS0.38
Dividend Yield1.46%
Beta0.59
50-Day Avg8.08
200-Day Avg9.24

About

Baolingbao Biology Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of functional sugar in China and internationally. The company offers prebiotics, including galacto-oligosaccharides, isomaltooligosaccharides, fructooligosaccharides, and xylooligosaccharides; sugar alcohols and sources, such as erythritol, trehalose, crystallized fructose, allulose, and maltotetrasaccharide; dietary fiber comprising polydextrose and resistant dextrin; modified, waxy corn, and corn starch products; starch sugar, which includes maltodextrose, high fructose syrup, solid corn syrup, maltodextrin, and glucose syrup; and animal nutrition products, such as baolekang and fubaokang. It also provides health plans comprising low sugar and calorie; nutritional fortification; microecological regulation; exclusive customization; texture optimization; medical aesthetics and daily chemical products; and antibiotic-reduced farming. The company's products are used in dairy products, drinks, snack food, health products and dietary supplements, candy, special dietary food, chemicals, and animal nutrition applications. It exports its products. The company was founded in 1997 and is based in Yucheng, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Zhou Yu
  • Employees1.50K
  • HeadquartersNo. 1, East Outer Ring Road, Yucheng, China, 251200, China
  • Websitehttps://www.blb-cn.com

Leadership

  • Mr. Zhou YuFinancial Director & CFO · b. 1978
  • Ms. Xia LiDeputy General Manager · b. 1976
  • Mr. Feng LiuExecutive Deputy GM, Board Secretary & Non-Independent Director · b. 1973
  • Mr. Qiang WangChairman & GM · b. 1962
  • Wen Xiu WenAccounting Supervisor

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue257.34M414.33M536.55M525.40M720.62M950.77M978.03M900.77M910.71M1.20B1.38B1.59B1.73B1.81B2.05B2.76B2.71B2.52B2.40B2.75B
Growth (%)-+61.00%+29.50%-2.08%+37.16%+31.94%+2.87%-7.90%+1.10%+31.36%+15.14%+15.65%+8.60%+4.34%+13.82%+34.58%-1.89%-6.96%-4.84%+14.54%
Cost of Revenue188.80M305.05M410.33M411.65M579.63M747.67M778.02M766.37M803.31M1.03B1.18B1.38B1.49B1.54B1.87B2.40B2.40B2.33B2.12B2.39B
Gross Profit68.54M109.28M126.22M113.75M140.99M203.10M200.00M134.39M107.40M162.58M202.23M213.32M241.32M266.54M186.77M368.24M308.40M197.52M278.47M364.72M
Gross Margin26.63%26.38%23.53%21.65%19.56%21.36%20.45%14.92%11.79%13.59%14.68%13.39%13.95%14.77%9.09%13.32%11.37%7.83%11.59%13.26%
Operating Expense37.22M59.82M77.21M78.00M99.44M141.84M119.24M104.53M94.61M125.83M152.53M155.42M187.25M220.26M126.04M132.31M148.17M133.51M124.50M175.92M
Operating Income31.32M49.45M49.01M35.75M41.55M61.26M80.76M29.86M12.79M36.75M49.70M57.90M54.07M46.28M60.74M235.93M160.23M64.01M153.97M188.80M
Operating Margin12.17%11.94%9.13%6.80%5.77%6.44%8.26%3.32%1.40%3.07%3.61%3.63%3.13%2.56%2.96%8.53%5.91%2.54%6.41%6.86%
EBITDA58.99M91.40M106.15M105.47M97.81M117.22M136.61M102.81M80.28M111.87M142.47M141.82M165.87M175.68M169.07M358.67M286.17M207.19M263.17M307.23M
EBITDA Margin22.92%22.06%19.78%20.07%13.57%12.33%13.97%11.41%8.82%9.35%10.34%8.90%9.59%9.73%8.23%12.97%10.55%8.21%10.96%11.17%
Net Income20.01M33.30M44.78M39.27M42.80M55.72M68.69M41.11M22.78M40.95M49.34M49.62M42.95M35.23M49.86M201.58M133.17M53.97M111.16M150.63M
Net Income Margin7.77%8.04%8.35%7.48%5.94%5.86%7.02%4.56%2.50%3.42%3.58%3.12%2.48%1.95%2.43%7.29%4.91%2.14%4.63%5.48%
R&D----4.20M5.95M34.63M30.59M32.59M40.19M42.14M51.44M58.52M60.31M63.66M100.61M101.57M11.30M9.54M13.78M
R&D as % of Total Revenue----0.58%0.63%3.54%3.40%3.58%3.36%3.06%3.23%3.38%3.34%3.10%3.64%3.74%0.45%0.40%0.50%
Interest Expense15.64M26.79M28.57M29.06M19.67M13.36M10.32M6.62M4.18M8.34M6.23M8.01M29.63M31.66M13.18M19.57M28.05M24.24M13.91M9.11M
Interest Expense % of Total Revenue6.08%6.47%5.33%5.53%2.73%1.40%1.06%0.73%0.46%0.70%0.45%0.50%1.71%1.75%0.64%0.71%1.03%0.96%0.58%0.33%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets507.93M601.90M743.91M1.08B1.03B1.11B1.11B1.68B1.77B1.91B1.93B2.11B2.58B2.52B2.62B3.03B3.01B2.66B2.67B2.78B
Total Liabilities395.40M408.62M505.85M421.50M329.46M352.06M295.31M240.88M316.69M435.44M423.43M581.79M1.04B951.76M1.02B1.22B1.00B675.41M632.44M547.81M
Total Equity112.53M193.28M238.05M662.61M703.11M760.13M817.06M1.44B1.45B1.48B1.51B1.52B1.54B1.57B1.60B1.81B2.00B1.98B2.04B2.23B
Cash120.20M49.07M152.92M395.37M152.53M138.02M129.32M361.32M123.27M274.33M262.88M231.17M416.28M415.99M485.25M585.44M375.95M242.74M254.95M273.98M
Total Debt280.56M350.97M440.47M367.97M230.59M168.87M144.59M96.66M76.16M131.66M136.66M260.46M499.00M490.00M235.34M401.09M505.81M247.96M261.36M-
Net Debt160.37M301.90M287.55M-27.39M78.06M30.85M15.27M-264.66M-47.11M-142.67M-126.23M29.28M82.72M74.01M-249.92M-184.35M129.86M5.22M6.40M-

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow19.12M78.98M110.77M44.51M27.45M171.70M94.15M85.60M101.77M77.49M108.98M-36.91M133.05M153.95M398.46M206.27M30.82M282.28M248.72M259.36M
Investing Cash Flow-13.43M-231.39M-69.18M-93.21M-111.19M-108.30M-57.49M-367.40M-318.71M15.96M-83.46M-125.71M-292.19M-43.82M-121.27M-175.51M-129.68M-148.09M-159.34M-
Financing Cash Flow74.41M86.42M56.93M285.40M-161.05M-74.39M-45.05M517.26M-33.46M36.60M-19.92M79.55M276.48M-209.93M-202.36M134.37M63.14M-270.14M-81.68M-
Capital Expenditure14.56M231.69M69.51M93.51M160.82M132.31M67.50M147.47M272.91M199.40M96.53M98.96M173.71M95.46M131.93M92.85M254.55M152.23M189.93M189.30M
Free Cash Flow4.56M-152.72M41.26M-49.00M-133.37M39.39M26.66M-61.87M-171.14M-121.91M12.46M-135.86M-40.66M58.50M266.53M113.42M-223.72M130.05M58.79M70.07M
Dividends Paid16.30M28.51M32.57M29.84M23.67M13.06M20.77M34.41M12.96M18.90M27.86M36.76M61.22M11.08M11.08M22.16M22.31M49.76M55.31M31.93M
FCF to OCF23.87%-193.37%37.25%-110.10%-485.90%22.94%28.31%-72.28%-168.17%-157.34%11.43%368.13%-30.56%38.00%66.89%54.99%-725.86%46.07%23.64%27.01%
Dividend Paid to FCF357.16%-18.67%78.94%-60.90%-17.75%33.17%77.93%-55.61%-7.57%-15.50%223.60%-27.05%-150.59%18.94%4.16%19.53%-9.97%38.26%94.08%45.58%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 5, 2014Oct 27, 2014Feb 27, 2015Apr 28, 2015Aug 19, 2015Oct 27, 2015Feb 24, 2016Apr 25, 2016Aug 24, 2016Oct 25, 2016Mar 1, 2017Apr 28, 2017Aug 25, 2017Oct 25, 2017Feb 27, 2018Apr 16, 2018Aug 29, 2018Oct 29, 2018Apr 29, 2019Aug 23, 2019Oct 30, 2019Apr 29, 2020Aug 22, 2020Oct 29, 2020Apr 29, 2021Aug 20, 2021Oct 27, 2021Apr 28, 2022Aug 24, 2022Oct 27, 2022Apr 27, 2023Aug 24, 2023Oct 27, 2023Feb 6, 2024Apr 29, 2024Jul 30, 2024Oct 29, 2024Apr 24, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------
EPS Actual0.030.050.050.030.040.070.080.020.050.080.070.050.050.040.030.010.040.030.01-0.020.040.040.020.010.040.050.030.030.040.060.020.020.040.060.02-0.000.040.04-0.010.080.030.020.150.260.120.140.050.060.040.040.020.060.120.090.030.110.110.040.150.08
Surprise------------------------------------------------------------
Timing-----------------Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-market-Pre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-----

Key Statistics & Ratios

Market Cap3.16B
Enterprise Value3.19B
Trailing P/E21.89
Forward P/E18.15
PEG Ratio1.91
Price / Sales1.11
Price / Book1.43
EPS0.38
Book Value6.12
Revenue (TTM)2.85B
Gross Profit (TTM)396.87M
EBITDA278.71M
Profit Margin4.93%
Operating Margin4.89%
Return on Equity6.31%
Return on Assets3.45%
Shares Outstanding379.98M
Shares Float258.78M
Beta0.59
Dividend Yield1.46%
Dividend Rate0.12
Payout Ratio31.63%

Dividends

20262×
0.03Oct 14, 20260.12Jul 14, 2026
20251×
0.06Jul 3, 2025
20242×
0.04Dec 10, 20240.08Mar 8, 2024
20231×
0.08Jun 20, 2023
20221×
0.06Jun 27, 2022
20211×
0.06Jun 3, 2021
20201×
0.03Jun 30, 2020
20191×
0.03Jul 17, 2019
20181×
0.09May 31, 2018
20171×
0.08Jul 17, 2017
20161×
0.06Apr 12, 2016
20151×
0.03Jun 24, 2015
20141×
0.05Jun 9, 2014
20131×
0.07Jun 4, 2013
20121×
0.04May 30, 2012
20101×
0.01Jun 3, 2010

Stock Splits

  • Jun 9, 201420:10
  • May 30, 201213:10
  • Jun 3, 20101.3:1